SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-23-016575
Filing Date
2023-06-05
Accepted
2023-06-05 09:22:13
Documents
15
Period of Report
2023-06-01
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K ctdh20230604_8k.htm   iXBRL 8-K 29715
2 EXHIBIT 4.1 ex_529530.htm EX-4.1 54363
3 EXHIBIT 10.1 ex_529531.htm EX-10.1 114591
  Complete submission text file 0001437749-23-016575.txt   389515

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA ctdh-20230601.xsd EX-101.SCH 4036
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ctdh-20230601_def.xml EX-101.DEF 13895
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE ctdh-20230601_lab.xml EX-101.LAB 18217
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ctdh-20230601_pre.xml EX-101.PRE 13917
9 EXTRACTED XBRL INSTANCE DOCUMENT ctdh20230604_8k_htm.xml XML 4373
Mailing Address PO BOX 1180 ALACHUA FL 32616-1180
Business Address 6714 NW 16TH STREET, SUITE B GAINESVILLE FL 32653 386-418-8060
Cyclo Therapeutics, Inc. (Filer) CIK: 0000922247 (see all company filings)

IRS No.: 593029743 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39780 | Film No.: 23991396
SIC: 2836 Biological Products, (No Diagnostic Substances)